SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Alexion Pharmaceuticals, Inc. (ALXN) -- Ignore unavailable to you. Want to Upgrade?


To: Biomaven who wrote (35)11/16/1999 4:25:00 AM
From: Jongmans  Read Replies (1) | Respond to of 824
 
However after one dose and apparently safe in 42 people.
Of course you can't expect they will give now information on the ongoing phase ll trial, but the fact they repeat this information now on this congress gives me a positive indication.

Fifty percent positive with one single dose, what will be the effect with multiple doses? The future will learn..

Martin